Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: A long-term cohort study

Digestive and Liver Disease

Volumn 32, Issue 9, 2000, Pages 782-791

  Madonia, S ^a   D'Amico, G ^a   Traina, M ^a   Gatto, G ^a   Virdone, R ^a   Salamone, N ^a   Licata, A ^a   Tarantino, I ^a   Pagliaro, L ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

Liver cirrhosis; Prognostic indicators; Sclerotherapy of oesophageal varices; Variceal bleeding

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS HEMORRHAGE; ESOPHAGUS ULCER; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LIGATION; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; STOMACH VARICES; THROMBOCYTE COUNT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034485737     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(00)80356-4     Document Type: Article

References (30)

1. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Practice guidelines
2. Portal hypertension and variceal bleeding: An AASLD single topic symposium
3. Role of sclerotherapy in the long term management of variceal bleeding: A meta-analysis
4. The treatment of portal hypertension: A meta-analytic review
5. Complications of endoscopic injection sclerotherapy: A review
6. Endoscopic injection sclerotherapy for 1000 patients with esophageal varices. A nine year prospective study
7. Analysis of long term endoscopic surveillance during follow up after variceal sclerotherapy from a 13-year experience
8. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis
9. Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy
10. Design and analysis of randomized clinical trials requiring prolonged observation. II. Analysis and examples
11. A framework for evaluating and conducting prognostic studies: An application to cirrhosis of the liver
12. Prognostic models in chronic liver disease: Validity, usefulness and future role
13. Natural History of cirrhosis: Predictors of death risk; overview of published studies and validation in a new test set
14. Natural history of chronic hepatitis C
15. Regression models for prognostic prediction: Advantages, problems and suggested solutions
16. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial
17. Endoscopic variceal ligation versus endoscopic sclerotherapy for the management of bleeding varices: A prospective randomized trial
18. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence
19. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices
20. A prospective randomized controlled trial of chronic esophageal variceal sclerotherapy
21. Factors affecting successful endoscopic sclerotherapy for esophageal varices
22. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study
23. Role of paraoesophageal collaterals and perforating veins on outcome of endoscopic sclerotherapy for oesophageal varices: An endosonographic study
24. Influence of paraesophageal venous collaterals on efficacy of endoscopic sclerotherapy for esophageal varices
25. Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding
26. Natural history of congestive gastropathy in cirrhosis
27. Endoscopic variceal sclerosis does not increase the risk of portal venous thrombosis
28. Variceal ulceration following sclerotherapy: Normal consequence or complication?
29. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis